Revaccination following CAR-T therapy: a needs assessment

Revaccination following CAR-T therapy: a needs assessment

Background: CD19-targeted chimeric antigen receptor T-cell (CAR-T) therapy has transformed treatment for relapsed/refractory large B-cell lymphoma, offering promising remission rates. However, it carries significant infectious risks, necessitating revaccination for infection prevention.Methods: This...

Full description

Saved in:
Bibliographic Details
Main Authors: Robert Clayden, Barbara Gunka, Brittany Salter, Audrey Y. H. Dong, Kylie Lepic, Gwynivere Davies, Amaris Balitsky
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Hematology
Subjects:
CAR-T
vaccination
LBCL
lymphoma
Online Access:https://www.tandfonline.com/doi/10.1080/16078454.2025.2519865
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.tandfonline.com/doi/10.1080/16078454.2025.2519865

Similar Items